New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareLivagen vs Syn-Ake

Livagen vs Syn-Ake

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Livagen
Skin & CosmeticAnti-Aging & Longevity
Syn-Ake
Summary
Livagen is a dipeptide bioregulator (Lys-Glu) developed by Professor Vladimir Khavinson, tissue-specific for the liver and thymus. It supports hepatocyte function, promotes liver cell regeneration, and modulates immune function via thymic activity. Research suggests benefits in chronic liver disease, hepatic aging, and immune restoration following liver damage.
Syn-Ake is a synthetic tripeptide that mimics waglerin-1, a peptide found in the venom of the Temple viper (Tropidolaemus wagleri). It acts as a reversible antagonist of muscular nicotinic acetylcholine receptors, temporarily reducing facial muscle contraction and smoothing dynamic wrinkles. Often called a 'synthetic Botox' in cosmetic marketing.
Half-Life
Short (minutes); gene-regulatory effects are sustained
Not applicable (topical; effect duration hours)
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
10 mg per day
0.01–0.1% (4–8 mg/g in clinical studies)
Frequency
Daily for 10–30 days
Twice daily
Key Benefits
  • Supports hepatocyte regeneration and liver tissue repair
  • Normalizes liver cell protein synthesis
  • Immune modulation via thymic activity
  • Potential benefits in chronic hepatitis and liver aging
  • Anti-aging effects on hepatic tissue
  • May support liver recovery after toxic insult or alcohol damage
  • Complementary to NAD+ and glutathione in liver health protocols
  • Reduces depth of dynamic wrinkles and expression lines
  • Reversible muscle-relaxing effect on facial muscles
  • Smooths forehead lines, crow's feet, and frown lines
  • Non-invasive alternative to injectable neurotoxins
  • Rapid onset relative to collagen-stimulating peptides
  • Well-studied in in vitro and clinical cosmetic trials
Side Effects
  • Generally well tolerated
  • Mild injection site reactions
  • No significant hepatotoxic effects reported at standard doses
  • Generally very well-tolerated topically
  • Rare skin sensitivity or contact dermatitis
  • Theoretical neuromuscular effects at systemic doses (not relevant topically)
Stacks With